Clinical trials: sponsored by Krystal Biotech, Inc.
Skin Roughness, Wrinkle
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
- Conditions
- Skin Roughness, Wrinkle, Fine Lines, Skin Thickness
- Trial name
- NCT04540900
- Testing
- KB301
- Where
- 4 sites in United States
- Volunteers
- 85 people, healthy volunteers welcome
- Sponsor
- Krystal Biotech, Inc.
Wrinkles in Decolletage, Pigmentation
A Study Assessing KB304 for the Treatment of Wrinkles in Women
The aim of this study is to investigate the safety and efficacy of KB304, an investigational gene therapy to correct moderate to severe wrinkles in the décolleté region (V-shaped chest area).
- Conditions
- Wrinkles in Decolletage, Pigmentation, Décolleté Wrinkles
- Trial name
- Pearl-2 (NCT06724900)
- Testing
- KB304, 0.9% Normal Saline (NS)
- Where
- United States
- Volunteers
- 19 people, healthy volunteers welcome
- Sponsor
- Krystal Biotech, Inc.